EOFLOW Co.Ltd (294090 KQ) stock market data APIs
₩1487.1514
0(0%)
as of March 23, 2026
Try our APIs with
free plan!
EOFLOW Co.Ltd Financial Data Overview
Price chart is built with
Anychart
EOFLOW Co., Ltd. develops, manufactures, and sells patch-type insulin pumps for diabetic patients in South Korea and the United States. The company offers EOPatch, a wearable insulin pump. It exports its products. The company was founded in 2011 and is headquartered in Seongnam-si, South Korea.
Prev. Close
1487.1514
Open
1487.1514
High
1487.1514
Low
1487.1514
52 wk Range
1490-1490
Market Cap
52 268 M
Shares Outstanding
35 079 K
Revenue
3 977 M
EPS
-172.1176
Beta
-0.26
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get EOFLOW Co.Ltd data using free add-ons & libraries
Get EOFLOW Co.Ltd Fundamental Data
EOFLOW Co.Ltd Fundamental data includes:
- Net Revenue: 3 977 M
- EBITDA: -123 910 176 768
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-09-30
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
EOFLOW Co.Ltd News
New
Medtronic to acquire wearable insulin patch maker EOFlow
Acquisition will expand company's ability to serve more people living with diabetes around the world within one seamless Medtronic ecosystem of support DUBLIN and SEONGNAM, South Korea, May 25, 2023 ...
Diabeloop and EOFlow Partner to Offer a Wearable AID With a Smartphone App
PARIS, Jan. 11, 2023 (GLOBE NEWSWIRE) -- EOFlow Co., Ltd. (KOSDAQ: 294090) (EOFlow or the Company), a provider of wearable drug delivery systems, and Diabeloop, a leader in diabetes automated treatm...
EOFlow Submits Application to the U.S. FDA for its Wearable Insulin Pump 'EOPatch'
Plans to finalize its U.S. distribution strategy in 2023 Aims to enter the U.S., the world's largest diabetes market, with its current disposable wearable insulin pump 'EOPatch' SAN JOSE, Calif. , De...
EOFlow and Zihipp Announce Joint Venture for Development of Innovative Solutions for Treatment of Obesity & NASH
Establishment of Joint Venture Company named SanPlena in the US Drug-device combination of EOFlow's smart wearable drug delivery platform and novel peptide derivatives developed by a team led by Prof....
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
